Paul Scott writes about the documentary, “Depression: Out of the Shadows,” which won a Peabody Award.
He criticizes that “its broad survey of the science of the illness included frequent appearances by Charles Nemeroff, M.D., a leading–some say powerful–mood disorders researcher from Emory University. Last fall, Nemeroff also became one of the most prominent psychiatrists to be rebuked for failing to disclose funds earned from the drug industry.” …
The heart of his critique, though, is this:
“That PBS producers either did not know about Nemeroff’s drug industry entanglements or did not believe they tainted his discussion of the science of depression is disappointing. Indeed, the science of the illness and antidepressant medications is far less uniformly agreed upon than is depicted in the documentary. Disputes are ongoing over the efficacy, mechanism of action, and “targeted” nature of antidepressants–blockbuster drugs that remain the recipient of favorable press coverage even while now going off patent.
But what made the praise bestowed on this PBS documentary particularly troubling were the erroneous, drug-industry serving statements made by Nemeroff within the film–statements which had the potential to negatively affect public health, and which the documentary left unchallenged.”
Read the entire piece.